Top Back to top

Impact of pre-existing invasive aspergillosis on allogeneic hematopoietic stem cell transplantation for treatment of acute leukaemia and myelodysplastic syndrome

Infectious Diseases Working Party (IDWP)
Study number:
Type of Stem Cell Treatment:
Myelodysplastic (MDS) or MDS/MPN
Acute Myeloid Leukaemia (AML)
Acute Lymphatic Leukaemia (ALL)
Short title:
IPAT study
Primary objective:
to determine if pre-existing IA influences non-relapse mortality after allo-HSCT
Key inclusion criteria:
first allo in patients with AL or MDS
Principal investigator:
Olaf Penack
Study coordinator email: